Redeye updates on Nepa following the Q1 results which showed continued hesitation from clients hurting the growth, but surprisingly strong cost control. The company is set to scale nicely when top-line growth returns. With completion of the cost saving program, full focus forwards is on profitable growth. Redeye makes a minor downward adjustment to its fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/